Exploiting the oncogenic state of colorectal cancer for therapeutic development

被引:0
|
作者
de Sousa e Melo, Felipe
机构
关键词
D O I
10.1158/1538-7445.AM2023-6134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6134
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Oncogenic role and therapeutic target of leptin signaling in colorectal cancer
    Zhou, Weiqiang
    Tian, Yuwang
    Gong, Hangjun
    Guo, Shanchun
    Luo, Chengyu
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (08) : 961 - 971
  • [2] Oncogenic signaling is coupled to colorectal cancer cell differentiation state
    Sell, Thomas
    Klotz, Christian
    Fischer, Matthias M.
    Astaburuaga-Garcia, Rosario
    Krug, Susanne
    Drost, Jarno
    Clevers, Hans
    Sers, Christine
    Morkel, Markus
    Bluethgen, Nils
    JOURNAL OF CELL BIOLOGY, 2023, 222 (06):
  • [3] Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy
    Hinze, Laura
    Labrosse, Roxane
    Degar, James
    Han, Teng
    Schatoff, Emma M.
    Schreek, Sabine
    Karim, Salmaan
    McGuckin, Connor
    Sacher, Joshua R.
    Wagner, Florence
    Stanulla, Martin
    Yuan, Chen
    Sicinska, Ewa
    Giannakis, Marios
    Ng, Kimmie
    Dow, Lukas E.
    Gutierrez, Alejandro
    CANCER DISCOVERY, 2020, 10 (11) : 1690 - 1705
  • [4] Oncogenic Role of BOLL in Colorectal Cancer
    Kang, Ki Joo
    Pyo, Jeung Hui
    Ryu, Kyung Ju
    Kim, Sung Jin
    Ha, Jung Min
    Choi, Kyu
    Hong, Sung Noh
    Min, Byung-Hoon
    Chang, Dong Kyung
    Son, Hee Jung
    Rhee, Poong-Lyul
    Kim, Jae J.
    Kim, Young-Ho
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (06) : 1663 - 1673
  • [5] Oncogenic Role of BOLL in Colorectal Cancer
    Ki Joo Kang
    Jeung Hui Pyo
    Kyung Ju Ryu
    Sung Jin Kim
    Jung Min Ha
    Kyu Choi
    Sung Noh Hong
    Byung-Hoon Min
    Dong Kyung Chang
    Hee Jung Son
    Poong-Lyul Rhee
    Jae J. Kim
    Young-Ho Kim
    Digestive Diseases and Sciences, 2015, 60 : 1663 - 1673
  • [6] HOW RELIABLE, IN TERMS OF ONCOGENIC DEVELOPMENT, ARE FUNCTIONAL MARKERS OF COLORECTAL-CANCER
    ROGNUM, TO
    BRANDTZAEG, P
    LANCET, 1983, 1 (8318): : 239 - 239
  • [7] Frequency, molecular characteristics, and therapeutic targeting of ROS1 oncogenic fusions in colorectal cancer
    Hussung, Saskia
    Akhoundova, Dilara
    Sivakumar, Smruthy
    Kahraman, Abdullah
    Zoche, Martin
    Rechsteiner, Markus
    Angst, Florian
    Britschgi, Christian
    Topfer, Antonia
    Moch, Holger
    Weber, Achim
    Sokol, Ethan
    Fritsch, Ralph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders
    Caspi, Michal
    Wittenstein, Amnon
    Kazelnik, Michal
    Shor-Nareznoy, Yarden
    Rosin-Arbesfeld, Rina
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 169 : 118 - 136
  • [9] Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression
    Silva, Sara
    Cavaco, Ana
    Basso, Bianca
    Mota, Joana
    Cruz-Duarte, Raquel
    Costa, Miguel
    Carvalho, Lara
    Lima, Ana
    Costa, Luis
    Ferreira, Ricardo
    Martins, Marta
    CANCERS, 2022, 14 (24)
  • [10] Oncogenic mutations as predictive factors in colorectal cancer
    Lievre, A.
    Blons, H.
    Laurent-Puig, P.
    ONCOGENE, 2010, 29 (21) : 3033 - 3043